2 square imprints A 025 (Permax 0.25 MG)
Generic Name: pergolide
Pill imprint 2 square imprints A 025 has been identified as Permax 0.25 MG.
Permax is used in the treatment of parkinson's disease; tourette's syndrome; hyperprolactinemia and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Permax 0.25 MG is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- pergolide
- Imprint:
- 2 square imprints A 025
- Strength:
- 0.25 MG
- Color:
- Green
- Size:
- 12.00 mm
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Valeant Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00187-0840
- Inactive Ingredients:
- croscarmellose sodium
ferric oxide
lactose
magnesium stearate
povidone
FD&C Blue No. 2
More about Permax (pergolide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
